Abstract: The present invention provides an energy-storing temperature control material, and belongs to the technical field of temperature control materials. In the energy-storing temperature control material provided in the present invention, the organic synthetic fiber based phase-change material has a three-dimensional dispersion effect, and can form a network constraint for remaining phase-change materials to reinforce mechanical properties of the materials, thereby fixing shapes of the materials and avoiding a liquid-crystal phase separation phenomenon in the phase-change process. The phase-change energy storage agent can absorb and release the heat by means of solid-liquid phase conversion of the material, to achieve the temperature control effect; and the phase-change temperature regulator can regulate a phase-change temperature range of the phase-change material, to make the energy-storing temperature control material suitable for climatic features of northern China.

Abstract: The present disclosure relates to a pulverulent composition comprising (a) at least one phosphate flame retardant synergist selected from hydrogen phosphate salt, dihydrogen phosphate salt, hydrate thereof and mixture thereof; (b) at least one flame retardant; and (c) at least one thermoplastic polymer. The present disclosure also relates to a 3D-printed object formed from the pulverulent composition and a process of forming 3D-printed object. The pulverulent composition shows good printability and the 3D-printed objects obtained from the thermoplastic powders not only have excellent flame-retardant performance but also have good mechanical properties.

Abstract: A generic inert bio-vector Salmonella sp. S9H and potential uses thereof are provided. The generic inert bio-vector Salmonella sp. S9H is derived from a continuous in-vitro culture of an inert bio-vector bacterium Salmonella sp. S9 by using LB solid and liquid culture media for passage to the fortieth generation. With a quantity of bacteria at a working concentration, the S9H does not cause non-specific agglutination reactions in sera or whole blood derived from humans, mice, cattle, pigs and poultry (including chickens, ducks, geese, turkeys, pigeons and quails); moreover, S9H has a property of carrying, and expressing and displaying different antigen factors derived from humans, mice, cattle, pigs and poultry (including chickens, ducks, geese, turkeys, pigeons and quails) on the surface thereof .

Abstract: The present invention provides an energy-storing temperature control material, and belongs to the technical field of temperature control materials. In the energy-storing temperature control material provided in the present invention, the organic synthetic fiber based phase-change material has a three-dimensional dispersion effect, and can form a network constraint for remaining phase-change materials to reinforce mechanical properties of the materials, thereby fixing shapes of the materials and avoiding a liquid-crystal phase separation phenomenon in the phase-change process. The phase-change energy storage agent can absorb and release the heat by means of solid-liquid phase conversion of the material, to achieve the temperature control effect; and the phase-change temperature regulator can regulate a phase-change temperature range of the phase-change material, to make the energy-storing temperature control material suitable for climatic features of northern China.

Abstract: The present invention relates to an inert carrier Salmonella and potential use thereof, which is expected to be developed into a new inert carrier bacteria, and can be applied to the development of an indirect agglutination test method for simple and rapid detection of antigens or infected antibodies. The inert carrier Salmonella has been deposited in CGMCC in Beijing on Mar. 18, 2019 with the accession number of CGMCC No. 17340, and is classified as Salmonella sp. with a strain code of S9. The Salmonella has no visible agglutination reaction with various chicken sera derived from different genetic backgrounds, i.e., it has no non-specific agglutination reaction with chicken sera derived from broad range of genetic backgrounds.

Abstract: A polymer matrix/nanoparticle composite (PMNC) comprises core-shell nanoparticles, where the core is made of a material that is different from the polymer matrix and at least part of the shell is made of the same monomer or polymer that is used for said polymer matrix, or is made of a monomer or polymer compatible with said matrix. The core of the nanoparticles has a refractive index that is different from the refractive index of the polymer used for the matrix, at least the matrix is made of transparent materials that do not absorb light.

Abstract: An electronic device for displaying an operation panel is provided in accordance with an aspect of the present disclosure. The operation panel displayed on a screen of the electronic device includes multiple levels of menus. The electronic device displays a first menu of the operation panel on the screen. When a second item being a subordinate item of a first item is selected, the electronic device hides the first menu showing the first item, and displays a second menu of the operation panel on the screen. The second menu includes a central section for identifying the second item.

Abstract: A kit for the prognosis of colorectal cancer, which includes reagents related in detecting the expression level of any one or more genes of the following five genes: BST1, as shown in SEQ ID NO:1; MGST1, as shown in SEQ ID NO:2, 3, 4, 5, 6, 7, 8, 9 or 10; HP, as shown in SEQ ID NO:11 or 12; RCAN3, as shown in SEQ ID NO:13, 14, 15, 16, 17, 18, 19, 20, 21 or 22; and SRA1, as shown in SEQ ID NO:23 or 24. The reagents are used to detect the expression level of any one or more of the above five genes in the preparation of a kit for the prognosis of colorectal cancer. The kit can be used to perform precise prognosis for a patient suffering from colorectal cancer, and has good clinical application prospects.

Abstract: The present invention relates to method and kit for performing a colorectal cancer assay. Especially a method including extracting total RNA from a peripheral blood sample obtained from a patient suspected of having or having colorectal cancer; contacting the total RNA, or cDNA or cRNA obtained from the total RNA, with one or more reagents specific for at least one target gene and no more than 100 target genes; and measuring the expression level of the at least one target gene and no more than 100 target genes. The at least one target gene and no more than 100 target genes includes one or more members selected from the group consisting of the KLRB1, KLRC2, KLRC3, KLRD1, KLRK1, CD247, RRAS2, SH2D1B, LCK, MRPS6, SPRY4, CYBB, DUSP2, PDE4D, SH2D2A, GZMB, INSR, ITGAM, VCAN, CD163, P2RY10, CD226, MRPL10, ITPRIPL2, CD2, and NUDT16 genes.

Abstract: The present invention provides a method for determining in vitro, in a peripheral blood sample, the probability for an individual to suffer from a colorectal cancer, using the comparison of the amount of expression products of nucleic acids of genes of the individual to be tested with the amount of expression products of nucleic acids of the same genes obtained from a CRC group of patients constituting the positive control and with the amount of expression products of nucleic acids of the same genes obtained from a CNC group of individuals constituting the negative control; and a kit comprising specific binding partners for said expression products.

Abstract: The present invention relates to method and kit for performing a colorectal cancer assay. Especially a method including extracting total RNA from a peripheral blood sample obtained from a patient suspected of having or having colorectal cancer; contacting the total RNA, or cDNA or cRNA obtained from the total RNA, with one or more reagents specific for at least one target gene and no more than 100 target genes; and measuring the expression level of the at least one target gene and no more than 100 target genes. The at least one target gene and no more than 100 target genes includes one or more members selected from the group consisting of the KLRB1, KLRC2, KLRC3, KLRD1, KLRK1, CD247, RRAS2, SH2D1B, LCK, MRPS6, SPRY4, CYBB, DUSP2, PDE4D, SH2D2A, GZMB, INSR, ITGAM, VCAN, CD163, P2RY10, CD226, MRPL10, ITPRIPL2, CD2, and NUDT16 genes.

Abstract: A method and kit for discriminating between breast cancer and benign breast disease by the determination of the expression level of at least one target gene having a nucleic acid sequence selected from the nucleic acid sequences set forth in SEQ ID NOs: 1, 2 or 3, 4 and 5 or 6 to obtain an expression profile for the patient, and the comparison of the expression profile of the patient with expression profiles of target genes from patients previously clinically classified as breast cancer and expression profiles of target genes from patients previously clinically classified as benign breast disease.

Abstract: A polymer matrix/nanoparticle composite (PMNC) comprises core-shell nanoparticles, where the core is made of a material that is different from the polymer matrix and at least part of the shell is made of the same monomer or polymer that is used for said polymer matrix, or is made of a monomer or polymer compatible with said matrix. The core of the nanoparticles has a refractive index that is different from the refractive index of the polymer used for the matrix, at least the matrix is made of transparent materials that do not absorb light.

Abstract: A method and kit for the prognosis of colorectal cancer where the method includes the steps of: a) obtaining a peripheral blood sample and extracting total RNA from the sample, b) contacting the total RNA with at least one reagent specific for at least one NK cell gene and no more than 25 specific reagents for 25 NK cell genes, c) determining the expression level of at least one and at most 25 NK cell genes to obtain an expression profile for the patient, d) analyzing the expression profile with expression profiles previously clinically classified as a good prognosis and as a poor prognosis, wherein if the expression profile is clustered with the poor prognosis profiles, then the patient is determined to have a poor prognosis, and if the expression profile is clustered with the good prognosis profiles, then the patient is determined to have a good prognosis.

Abstract: A method and kit are related to discriminating between breast cancer and benign breast disease by the determination of the expression level of at least one target gene including a nucleic acid sequence selected from the nucleic acid sequences set forth in SEQ ID NOs: 1, 2 or 3, 4 and 5 or 6 to obtain an expression profile for the patient, and the comparison of the expression profile of the patient with expression profiles of target genes from patients previously clinically classified as breast cancer and expression profiles of target genes from patients previously clinically classified as benign breast disease.

Abstract: A kit for the prognosis of colorectal cancer, which includes reagents related in detecting the expression level of any one or more genes of the following five genes: BST1, as shown in SEQ ID NO:1; MGST1, as shown in SEQ ID NO:2, 3, 4, 5, 6, 7, 8, 9 or 10; HP, as shown in SEQ ID NO:11 or 12; RCAN3, as shown in SEQ ID NO:13, 14, 15, 16, 17, 18, 19, 20, 21 or 22; and SRA1, as shown in SEQ ID NO:23 or 24. The reagents are used to detect the expression level of any one or more of the above five genes in the preparation of a kit for the prognosis of colorectal cancer. The kit can be used to perform precise prognosis for a patient suffering from colorectal cancer, and has good clinical application prospects.

Abstract: An electronic device for displaying an operation panel is provided in accordance with an aspect of the present disclosure. The operation panel displayed on a screen of the electronic device includes multiple levels of menus. The electronic device displays a first menu of the operation panel on the screen. When a second item being a subordinate item of a first item is selected, the electronic device bides the first menu showing the first item, and displays a. second menu of the operation panel on the screen. The second menu includes a central section for identifying the second item.

Abstract: The disclosure relates to an anti-clogging mesh abrasive cloth, which is one type of coated abrasive tool. The anti-clogging mesh abrasive cloth comprises a substrate, a prime adhesive coating layer painted on the substrate, an abrasive layer planted on the prime adhesive coating layer, and a deposited adhesive coating layer covering on top of the abrasive layer. The substrate of the anti-clogging mesh abrasive cloth is mesh cloth with a plurality of uniformly distributed large meshes and small meshes. The large meshes can facilitate discharge of chips generated during grinding. The small meshes allow the plane around the large meshes to be anti-clogging. The combination of the large meshes and the small meshes makes the anti-clogging mesh abrasive cloth anti-clogging and suitable for grinding the materials apt to causing blockage while being grinded, such as wood, paint and putty.

Abstract: The invention is a new Velcro-backed abrasive cloth. It is used in the coated abrasives industry. Its uniqueness is in the construction. It is formed by a cloth with Velcro on one side (1), after the cloth is dipped in resin, the side with no Velcro is coated with a layer of primer (2), and an abrasive layer (3) is then planted on top of the primer. On top of the abrasive layer, a multi-layer adhesive (4) is then planted. There is an anti clogging coating, an anti static coating or a combination of both on the multi-layer adhesive. This new Velcro backed abrasive cloth utilizes a napped fabric as the base material. The abrasives are directly planted onto the resin treated base material thus reducing the manufacturing steps and lowering costs. The unique construction of the base material extends the product lifetime and increases the sanding efficiency.

Abstract: The disclosure relates to an anti-clogging mesh abrasive cloth, which is one type of coated abrasive tool. The anti-clogging mesh abrasive cloth comprises a substrate, a prime adhesive coating layer painted on the substrate, an abrasive layer planted on the prime adhesive coating layer, and a deposited adhesive coating layer covering on top of the abrasive layer. The substrate of the anti-clogging mesh abrasive cloth is mesh cloth with a plurality of uniformly distributed large meshes and small meshes. The large meshes can facilitate discharge of chips generated during grinding. The small meshes allow the plane around the large meshes to be anti-clogging. The combination of the large meshes and the small meshes makes the anti-clogging mesh abrasive cloth anti-clogging and suitable for grinding the materials apt to causing blockage while being grinded, such as wood, paint and putty.